Impact of baseline patient characteristics on dupilumab efficacy in type 2 asthma
Volume: 58, Issue: 4, Pages: 2004605 - 2004605
Published: Jul 29, 2021
Abstract
Dupilumab treatment versus placebo improved exacerbation rate and lung function outcomes in patients with uncontrolled moderate-to-severe asthma and high type 2 biomarkers at baseline, regardless of baseline characteristics in the phase 3 QUEST...
Paper Details
Title
Impact of baseline patient characteristics on dupilumab efficacy in type 2 asthma
Published Date
Jul 29, 2021
Volume
58
Issue
4
Pages
2004605 - 2004605
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History